BiomX Inc.
PHGE
$0.5501
$0.00330.60%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.42M | 2.51M | 6.03M | 3.25M | 2.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.43M | 7.76M | 8.51M | 10.53M | 9.59M |
| Operating Income | -7.43M | -7.76M | -8.51M | -10.53M | -9.59M |
| Income Before Tax | -6.04M | -7.66M | -14.51M | 9.64M | 4.48M |
| Income Tax Expenses | 2.00K | 1.00K | 3.00K | -- | 5.00K |
| Earnings from Continuing Operations | -6.04M | -7.66M | -14.51M | 9.64M | 4.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.04M | -7.66M | -14.51M | 9.64M | 4.47M |
| EBIT | -7.43M | -7.76M | -8.51M | -10.53M | -9.59M |
| EBITDA | -7.14M | -7.52M | -7.59M | -10.21M | -9.26M |
| EPS Basic | -0.19 | -0.33 | -0.80 | 0.31 | 0.14 |
| Normalized Basic EPS | -0.12 | -0.21 | -0.22 | 0.40 | 0.41 |
| EPS Diluted | -0.19 | -0.33 | -0.89 | 0.31 | -0.69 |
| Normalized Diluted EPS | -0.12 | -0.21 | -0.22 | 0.40 | 0.27 |
| Average Basic Shares Outstanding | 31.31M | 23.10M | 18.24M | 16.37M | 6.98M |
| Average Diluted Shares Outstanding | 31.31M | 23.10M | 18.24M | 16.37M | 10.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |